Engineer
Evaluate
Manufacture
The AVATAR platform brings physiologically relevant tumor microenvironment (TME) control into cell therapy workflows, improving potency, persistence, and predictability for solid tumor therapies.
From Discovery to Clinical Manufacturing
The AVATAR platform is designed to optimize cell therapy potency at every stage offering development
Functional Evaluation
Microenvironment
driven mfg
seamless r&D to
GMP continuity
closed, automated
scale-up
tme-informed
potency insights
Integrate physiologic oxygen & pressure control directly into GMP workflows to train cells for environments they face in vivo
Our platforms share identical environmental profiles and formats, reducing technical transfer risk & accelerating translation
Reproducible yields and consistent phenotypes supported by closed, automated workflows designed for manufacturing
Generate real-time, label-free potency data under physiologically relevant conditions to inform faster, more predictive decisions
validated by leaders in cell & gene therapy
Setting a new standard for oncology cell therapy development
Phenotype That Persists
Selective expansion of Tcm and Tscm populations associated with efficacy.
Sustained Killing Power
Persistent cytotoxicity through repeated tumor challenges under harsh TME conditions easy.
Built for gmp workflows
Drop-in compatibility enables faster deployment with lower infrastructure costs.
latest news
research & insights
Explore our news, applications & publications
White Paper
Unlocking organoid potential through improved culture conditions
Yelena Bronevetsky
September 2025
Publication
PHPT1 acts as an inhibitor in high-altitude pulmonary hypertension via negative TRPV5 signaling regulation
Journal of Translational Medicine (2025)
News
To Bring Cell Culture into the Future, Consider Microenvironments
James Lim
December 2025
transform your cell therapy development
Interested in learning more about the AVATAR platform?